Mycosis fungoides epidemiology and demographics: Difference between revisions
No edit summary |
Mahshid |
||
| Line 22: | Line 22: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Revision as of 22:04, 26 November 2017
|
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age. The median age at diagnosis of Sézary syndrome is 60 years of age. In the United States, males are more commonly affected with cutaneous T cell lymphoma than females. In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.[1]
Epidemiology and demographics
Age
- The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age.
- The median age at diagnosis of Sézary syndrome is 60 years of age.
Gender
In the United States, males are more commonly affected with cutaneous T cell lymphoma than females.[1]
Race
In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.[1]
References
- ↑ 1.0 1.1 1.2 Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016